Company Search:
Advanced Search
Sponsored Links
Icad, Inc. Company Snapshot
Icad, Inc. operates in the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Icad with three other companies in this sector in the United States: Cytosorbents Corporation (2018 sales of $22.50 million of which 100% was Medical technology), Transenterix Inc ($24.10 million of which 100% was Medical Device), and TearLab Corp ($25.00 million of which 100% was Point of Care).

Sales Analysis. Icad reported sales of $25.62 million for the year ending December of 2018. This represents a decrease of 8.8% versus 2017, when the company's sales were $28.10 million. Contributing to the drop in overall sales was the 10.6% decline in Therapy, from $9.79 million to $8.76 million. There were also decreases in sales in Detection (down 7.9% to $16.86 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Icad, Inc.
  Stock Performance Chart for Icad, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2020): 11.98
(Figures in U.S. Dollars)
1 Week 41.3%   13 Weeks 27.3%  
4 Weeks 74.6%   52 Weeks 119.4%  
Icad, Inc. Key Data:
  Ticker: ICAD Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2018 Sales 25,621,000
(Year Ending Jan 2019).
Employees: 95
  Currency: U.S. Dollars Market Cap: 231,387,351
  Fiscal Yr Ends: December Shares Outstanding: 19,314,470
  Share Type: Common Closely Held Shares: 2,198,075
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.